ATE332126T1 - Geschmacksmaskierte pharmazeutische zusammensetzungen - Google Patents

Geschmacksmaskierte pharmazeutische zusammensetzungen

Info

Publication number
ATE332126T1
ATE332126T1 AT98953209T AT98953209T ATE332126T1 AT E332126 T1 ATE332126 T1 AT E332126T1 AT 98953209 T AT98953209 T AT 98953209T AT 98953209 T AT98953209 T AT 98953209T AT E332126 T1 ATE332126 T1 AT E332126T1
Authority
AT
Austria
Prior art keywords
flavor
pharmaceutical compositions
masked pharmaceutical
masked
spheronizing
Prior art date
Application number
AT98953209T
Other languages
English (en)
Inventor
Michael Augello
Ronald S Vladyka Jr
Sheila M Dell
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Application granted granted Critical
Publication of ATE332126T1 publication Critical patent/ATE332126T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98953209T 1997-10-03 1998-09-30 Geschmacksmaskierte pharmazeutische zusammensetzungen ATE332126T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/942,962 US5904937A (en) 1997-10-03 1997-10-03 Taste masked pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE332126T1 true ATE332126T1 (de) 2006-07-15

Family

ID=25478887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98953209T ATE332126T1 (de) 1997-10-03 1998-09-30 Geschmacksmaskierte pharmazeutische zusammensetzungen

Country Status (15)

Country Link
US (1) US5904937A (de)
EP (1) EP1027038B1 (de)
JP (2) JP2001518491A (de)
KR (1) KR100563342B1 (de)
CN (1) CN1154481C (de)
AT (1) ATE332126T1 (de)
AU (1) AU1063799A (de)
BR (1) BR9812590B1 (de)
CA (1) CA2303177C (de)
DE (1) DE69835162T2 (de)
DK (1) DK1027038T3 (de)
IL (1) IL135121A (de)
NO (1) NO20001670L (de)
PL (1) PL339568A1 (de)
WO (1) WO1999017748A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1202716A1 (de) 1999-08-17 2002-05-08 Novartis Consumer Health S.A. Schnelllösliche dosierungsform und verfahren zu deren herstellung
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
IL134701A0 (en) * 2000-02-23 2001-04-30 J P M E D Ltd Homogeneous solid matrix containing vegetable proteins
BR0109602A (pt) 2000-03-30 2004-06-29 Bristol Myers Squibb Co Glóbulos de liberação controlada contendo estavudina
EP1252886A1 (de) * 2001-04-27 2002-10-30 Universiteit Gent Pharmazeutische Pelletformulierungen für eine kontrollierte Freisetzung
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
BR0206979A (pt) * 2001-02-05 2004-04-20 Scherer Technologies Inc R P Métodos e composições para reduzir o paladar de agentes farmaceuticamente ativos
US9820982B2 (en) 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
EP1411899B1 (de) * 2001-08-01 2009-03-11 Novartis AG Zusammensetzung zur maskierung des geschmacks
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
DK1589944T3 (da) * 2003-02-06 2012-03-19 Gebro Pharma Gmbh Farmaceutiske tilberedninger og fremgangsmåde til produktion heraf
JP4643899B2 (ja) * 2003-10-20 2011-03-02 エスエス製薬株式会社 イブプロフェン含有錠剤およびその製造方法
CA2618966C (en) * 2005-08-10 2014-05-13 Shionogi & Co., Ltd. Bitterness-reducing agent
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
JP2007131561A (ja) * 2005-11-09 2007-05-31 Ss Pharmaceut Co Ltd 経口固形製剤及びその製造法
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
MX2009003771A (es) * 2006-10-10 2009-07-22 Penwest Pharmaceuticals Co Formulaciones robustas de liberacion sostenida.
EP1935405A1 (de) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Im Mund zerfallende Tabletten
AU2009289464B2 (en) * 2008-09-04 2015-12-10 Farnam Companies, Inc. Chewable sustained release formulations
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
SG174125A1 (en) 2009-04-02 2011-10-28 Merck Serono Sa Dihydroorotate dehydrogenase inhibitors
WO2011087705A2 (en) * 2009-12-22 2011-07-21 Fmc Corporation Fine particle croscarmellose and uses thereof
WO2012049156A1 (en) * 2010-10-12 2012-04-19 Bayer Animal Health Gmbh Non-starch based soft chewables
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
US9855276B2 (en) 2012-10-25 2018-01-02 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
HUE042032T2 (hu) 2013-02-25 2019-06-28 Aurigene Discovery Tech Ltd Triszubsztituált benzotriazol-származékok, melyek dihidro-orotát-oxigenáz-inhibitor hatásúak
CN111803465B (zh) * 2013-03-15 2023-05-09 阿根塔创新有限公司 可咀嚼配制物
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
AU2014340182B2 (en) 2013-10-22 2019-05-23 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
US11253501B2 (en) * 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
EP3506894B1 (de) 2016-08-31 2023-08-23 The General Hospital Corporation Macrophagen/mikroglia bei nervenentzündungen im zusammenhang mit neurodegenerativen erkrankungen
WO2018154088A1 (en) 2017-02-24 2018-08-30 Merck Patent Gmbh 1, 4, 6-trisubstituted-2-alkyl-1h-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors
IL270066B2 (en) 2017-04-24 2023-10-01 Aurigene Oncology Ltd Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
WO2019017995A1 (en) * 2017-07-20 2019-01-24 Aztherapies, Inc. FORMULATIONS OF CROMOLYNE SODIUM POWDER AND IBUPROFEN
EP3508199A1 (de) * 2018-01-05 2019-07-10 Dompé farmaceutici S.p.A. Schnell freisetzende pharmazeutische zusammensetzungen mit ketoprofen-lysinsalz
JP2021529771A (ja) 2018-07-02 2021-11-04 ザ ジェネラル ホスピタル コーポレイション クロモリンナトリウムおよびα−ラクトースの粉末製剤
US12383528B2 (en) 2018-12-10 2025-08-12 The General Hospital Corporation Cromolyn esters and uses thereof
EP3804531A1 (de) * 2019-10-11 2021-04-14 Begapinol Dr. Schmidt GmbH Granulierung von topinambur
JP2023520580A (ja) 2020-04-06 2023-05-17 ザ ジェネラル ホスピタル コーポレイション コロナウイルス誘発炎症状態の処置方法
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
WO2022146914A1 (en) 2020-12-28 2022-07-07 The General Hospital Corporation Cromolyn derivatives and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5225201A (en) * 1991-08-23 1993-07-06 Minnesota Mining And Manufacturing Company Salsalate tablet
EP0619731B1 (de) * 1991-12-30 2000-10-04 Fmc Corporation Zusammensetzung auf der basis von mikrokristalliner zellulose für die herstellung von kugelförmigen teilchen
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
WO1995005165A1 (en) * 1993-08-13 1995-02-23 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5529783A (en) * 1994-12-19 1996-06-25 Mcneil-Ppc, Inc. Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules

Also Published As

Publication number Publication date
DE69835162T2 (de) 2007-05-31
BR9812590A (pt) 2000-08-01
EP1027038A1 (de) 2000-08-16
EP1027038A4 (de) 2005-02-09
US5904937A (en) 1999-05-18
NO20001670L (no) 2000-05-22
AU1063799A (en) 1999-04-27
IL135121A0 (en) 2001-05-20
CN1154481C (zh) 2004-06-23
KR20010024375A (ko) 2001-03-26
WO1999017748A1 (en) 1999-04-15
BR9812590B1 (pt) 2009-01-13
JP2007137902A (ja) 2007-06-07
CA2303177A1 (en) 1999-04-15
DE69835162D1 (de) 2006-08-17
DK1027038T3 (da) 2006-09-18
CN1273527A (zh) 2000-11-15
PL339568A1 (en) 2000-12-18
IL135121A (en) 2005-07-25
EP1027038B1 (de) 2006-07-05
JP2001518491A (ja) 2001-10-16
KR100563342B1 (ko) 2006-03-22
NO20001670D0 (no) 2000-03-31
CA2303177C (en) 2005-12-06

Similar Documents

Publication Publication Date Title
DE69835162D1 (de) Geschmacksmaskierte pharmazeutische zusammensetzungen
NO934315D0 (no) Farmas!ytisk b{rer
DK0605497T3 (da) Lægemiddelbærer af faste lipidpartikler (faste lipidnanosfærer (SLN)
UY24888A1 (es) Tabletas de oxacarbazepina recubiertas de pelicula
ES2080796T3 (es) Formulaciones de productos farmaceuticos de liberacion prolongada.
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
CA2266629A1 (en) Taste-masked microcapsule compositions and methods of manufacture
MX9701465A (es) Formulacion de acetaminofeno, de liberacion sostenida.
ATE281886T1 (de) Yttria partikelförmiges gut
ES2130666T3 (es) Procedimiento de revestimiento de particulas.
ATE217789T1 (de) Angenehm schmeckende pharmazeutische zusammensetzungen
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
ES2076358T3 (es) Granulados con elevado contenido de ibuprofeno.
ATE239456T1 (de) Pharmazeutische formulierung in form eines trockenen pulvers
ATE290854T1 (de) Carbamazepinformulierung mit verzögerter freigabe
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
ATE87467T1 (de) Pharmazeutische zubereitung.
DE69827466D1 (de) Geschmacksneutrale pharmazeutische zusammensetzungen
WO2002028424A3 (en) Kyberdrug as autovaccines with immune-regulating effects
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung
DE69012031D1 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
DE60001717D1 (de) Mikrokapseln mit verzögerter freisetzung von wirkstoffen
ATE376827T1 (de) Solid darreichungsform enthaltend koffein
RU93013175A (ru) Лекарственный препарат противоопухолевого действия
KR20000061972A (ko) 향기 치료요법에 쓰는 약용식물을 이용한 기능성 팬시용품

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties